Diagnostic Medical Systems Valuation
Is 0RIA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0RIA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 0RIA's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 0RIA's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0RIA?
Key metric: As 0RIA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 0RIA's PS Ratio? | |
|---|---|
| PS Ratio | 0.3x |
| Sales | €46.53m |
| Market Cap | €14.59m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.7x |
| Enterprise Value/EBITDA | -20.2x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 0RIA's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 10.9x | ||
IHC Inspiration Healthcare Group | 0.4x | 13.6% | UK£14.6m |
EMVC EMV Capital | 6.3x | 49.2% | UK£11.3m |
POLX Polarean Imaging | 12.6x | 57.3% | UK£18.7m |
OBI Ondine Biomedical | 24.3x | 66.0% | UK£22.5m |
0RIA Diagnostic Medical Systems | 0.3x | n/a | €14.6m |
Price-To-Sales vs Peers: 0RIA is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (10.9x).
Price to Sales Ratio vs Industry
How does 0RIA's PS Ratio compare vs other companies in the GB Medical Equipment Industry?
| 5 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| Industry Avg. | 3.0x | 6.3% | |
0RIA Diagnostic Medical Systems | 0.3x | n/a | US$15.29m |
SPEC INSPECS Group | 0.3x | 5.5% | US$69.15m |
YGEN Yourgene Health | 0.6x | n/a | US$20.48m |
| 5 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
| Industry Avg. | 3.0x | 22.5% | |
0RIA Diagnostic Medical Systems | 0.3x | n/a | US$15.29m |
Price-To-Sales vs Industry: 0RIA is good value based on its Price-To-Sales Ratio (0.3x) compared to the UK Medical Equipment industry average (3x).
Price to Sales Ratio vs Fair Ratio
What is 0RIA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.3x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 0RIA's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Guerbet
€331.6m
Engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions.
0ELV
€26.50
7D
-8.0%
1Y
42.5%
LNA Santé
€242.3m
Engages in the management and operation of health establishments.
0OR2
€23.70
7D
-6.7%
1Y
17.3%
Arjo
SEK 8.9b
Develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally.
0HQ8
SEK 32.93
7D
-4.0%
1Y
-11.1%